Shi R - Search Results

1

Niemann-Pick disease type C1(NPC1) is involved in resistance against imatinib in the imatinib-resistant Ph+ acute lymphoblastic leukemia cell line SUP-B15/RI.

Naren D, Wu J, Gong Y, Yan T, Wang K, Xu W, Yang X, Shi F, Shi R. Naren D, et al. Among authors: shi r, shi f. Leuk Res. 2016 Mar;42:59-67. doi: 10.1016/j.leukres.2016.01.007. Epub 2016 Jan 16. Leuk Res. 2016. PMID: 26818574

2

Mammalian target of rapamycin inhibitor rapamycin enhances anti-leukemia effect of imatinib on Ph+ acute lymphoblastic leukemia cells.

Yang X, He G, Gong Y, Zheng B, Shi F, Shi R, Yang X. Yang X, et al. Among authors: shi r, shi f. Eur J Haematol. 2014 Feb;92(2):111-20. doi: 10.1111/ejh.12202. Epub 2014 Jan 6. Eur J Haematol. 2014. PMID: 24112092

3

Curcumin induces apoptosis via simultaneously targeting AKT/mTOR and RAF/MEK/ERK survival signaling pathways in human leukemia THP-1 cells.

Guo Y, Shan Q, Gong Y, Lin J, Shi F, Shi R, Yang X. Guo Y, et al. Among authors: shi r, shi f. Pharmazie. 2014 Mar;69(3):229-33. Pharmazie. 2014. PMID: 24716415

4

The MEK1/2 inhibitor U0126 reverses imatinib resistance through down-regulating activation of Lyn/ERK signaling pathway in imatinib-resistant K562R leukemia cells.

Shi R, Lin J, Guo Y, Gong YP. Shi R, et al. Pharmazie. 2014 May;69(5):346-52. Pharmazie. 2014. PMID: 24855825

5

The antileukemia roles of PP242 alone or in combination with daunorubicin in acute leukemia.

Shi F, Yang X, Gong Y, Shi R, Yang X, Naren D, Wu J. Shi F, et al. Among authors: shi r. Anticancer Drugs. 2015 Apr;26(4):410-21. doi: 10.1097/CAD.0000000000000200. Anticancer Drugs. 2015. PMID: 25535978

6

The antileukemia effect of metformin in the Philadelphia chromosome-positive leukemia cell line and patient primary leukemia cell.

Shi R, Lin J, Gong Y, Yan T, Shi F, Yang X, Liu X, Naren D. Shi R, et al. Among authors: shi f. Anticancer Drugs. 2015 Oct;26(9):913-22. doi: 10.1097/CAD.0000000000000266. Anticancer Drugs. 2015. PMID: 26186064

7

Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.

Shi F, Len Y, Gong Y, Shi R, Yang X, Naren D, Yan T. Shi F, et al. Among authors: shi r. PLoS One. 2015 Aug 28;10(8):e0136746. doi: 10.1371/journal.pone.0136746. eCollection 2015. PLoS One. 2015. PMID: 26317515 Free PMC article.

8

High-expressing cystic fibrosis transmembrane conductance regulator interacts with histone deacetylase 2 to promote the development of Ph+ leukemia through the HDAC2-mediated PTEN pathway.

Yan T, Leng Y, Yang X, Gong Y, Sun H, Wang K, Xu W, Zheng Y, Naren D, Shi R. Yan T, et al. Among authors: shi r. Leuk Res. 2017 Jun;57:9-19. doi: 10.1016/j.leukres.2017.02.004. Epub 2017 Feb 16. Leuk Res. 2017. PMID: 28235656

9

[The Mechanism of Combination using mTORC1/2 Inhibitor and Imatinib to Suppress Cell Proliferation of Ph ⁺ALL Cell Line].

Wu JH, Shi FF, Gong YP, Shi R. Wu JH, et al. Among authors: shi r, shi ff. Sichuan Da Xue Xue Bao Yi Xue Ban. 2017 Mar;48(2):216-220. Sichuan Da Xue Xue Bao Yi Xue Ban. 2017. PMID: 28612529 Chinese.

10

Clinical features and outcome of pediatric acute lymphoblastic leukemia with low peripheral blood blast cell count at diagnosis.

Dai Q, Zhang G, Yang H, Wang Y, Ye L, Peng L, Shi R, Guo S, He J, Jiang Y. Dai Q, et al. Among authors: shi r. Medicine (Baltimore). 2021 Jan 29;100(4):e24518. doi: 10.1097/MD.0000000000024518. Medicine (Baltimore). 2021. PMID: 33530278 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,868 results

Search Page

Filters